This focused series is directed to the thoracic surgeons who are performing the minimally invasive surgery for early-stage lung cancer. Experts on each minimally invasive approach will comprehensively introduce their techniques and the results of their oncological clearance. Further prospective randomized controlled trials that compare each minimally invasive approach for early-stage lung cancer are needed to evaluate the oncological efficacy of these minimally invasive approaches.
Long-term outcomes of 3-port VATS lobectomy with selective mediastinal lymphadenectomy for clinical stage I non-small cell lung cancer
Prognostic factors and recurrence dynamics after multiple-port video-assisted thoracoscopic lobectomy for clinical T1-3N0 non-small cell lung cancer
Impact of the number of resected lymph nodes during multi-portal VATS lobectomy for clinical N0 non-small cell lung cancer
The series “Oncological Clearance of VATS Lobectomy for Clinical N0 Non-small Cell Lung Cancer” was commissioned by the editorial office, Video-Assisted Thoracic Surgery without any sponsorship or funding. Mingyon Mun is serving as the unpaid Guest Editor for the series.